AUGA:LSE:LSE-UBS (Irl) ETF plc - MSCI Australia UCITS ETF (hedged to GBP) A-acc (GBX)

ETF | Others |

Last Closing

USD 2529

Change

+12.50 (+0.50)%

Market Cap

N/A

Volume

2.70K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.39 (+0.14%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+3.50 (+1.75%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-2.79 (-1.95%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.57%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.10 (+0.58%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.35 (+0.57%)

USD 266.08B
0QZO:LSE 0QZO

+0.10 (+0.09%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.18 (+0.60%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

-0.86 (-0.53%)

USD 202.26B

ETFs Containing AUGA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.02% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.02% 69% C- 68% D+
Trailing 12 Months  
Capital Gain 22.68% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.68% 74% C 71% C-
Trailing 5 Years  
Capital Gain 53.16% 71% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.16% 70% C- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 11.70% 69% C- 71% C-
Dividend Return 11.70% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.66% 64% D 79% B-
Risk Adjusted Return 109.78% 96% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike